The GLP is committed to full transparency. Download and review our 2019 Annual Report

fda

Who benefits most from FDA’s ‘accelerated’ drug approvals? Patients or drugmakers?

Increasing reliance on this and other means of moving drugs quickly to market have many critics worried, given that drugmakers ...